[Effect of CYP2C19 gene polymorphism on eradication treatment efficacy of Helicobacter pylori infection]

Eksp Klin Gastroenterol. 2009:(4):128-32.
[Article in Russian]
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Amoxicillin / administration & dosage
  • Amoxicillin / pharmacokinetics
  • Amoxicillin / therapeutic use
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Breath Tests
  • Clarithromycin / administration & dosage
  • Clarithromycin / pharmacokinetics
  • Clarithromycin / therapeutic use
  • Cohort Studies
  • Cytochrome P-450 CYP2C19
  • DNA / genetics
  • Drug Therapy, Combination
  • Endoscopy, Digestive System
  • Female
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / enzymology
  • Helicobacter Infections / epidemiology
  • Helicobacter Infections / microbiology
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / isolation & purification
  • Humans
  • Male
  • Metabolic Clearance Rate
  • Moscow / epidemiology
  • Omeprazole / administration & dosage
  • Omeprazole / pharmacokinetics
  • Omeprazole / therapeutic use
  • Peptic Ulcer / drug therapy*
  • Peptic Ulcer / enzymology
  • Peptic Ulcer / epidemiology
  • Peptic Ulcer / microbiology
  • Polymorphism, Single Nucleotide*
  • Prospective Studies

Substances

  • Amoxicillin
  • DNA
  • Aryl Hydrocarbon Hydroxylases
  • CYP2C19 protein, human
  • Cytochrome P-450 CYP2C19
  • Clarithromycin
  • Omeprazole